NCT07820280 "Effectiveness of Kaltenborn Mobilization Techniques Versus Maitland Mobilization on Management of Cervicogenic Headache
| NCT ID | NCT07820280 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ibadat International University, Islamabad |
| Condition | Cervicogenic Headache |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2026-03-20 |
| Primary Completion | 2026-09-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2026-03-20 with a primary completion date of 2026-09-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
EFFECTIVENESS OF KALTENBORN MOBILIZATION TECHNIQUES VERSUS MAITLAND MOBILIZATION ON MANAGEMENT OF CERVICOGENIC HEADACHE
Eligibility Criteria
Inclusion Criteria: * Age: 18-40 yrs * Gender: male/female * Unilateral neck pain and stiffness * Cervicogenic headache confirmed with Cervical Flexion Rotation Test * Cervical spine ROM\>10° * Unilateral headache * Headache triggered on neck extension Exclusion Criteria: * Congenital conditions of cervical spine * Disc herniation * Cervical radiculopathy * Myelopathy * Cervical fracture/ trauma past 3 months * Vestibular dysfunction/ VBI * TMJ dysfunction related headache * Whiplash injury * Other types of headache i-e tension type, migraine or cluster type
Contact & Investigator
Marium Khalid, Ms-OMPT
PRINCIPAL INVESTIGATOR
Ibadat International University, Islamabad
Frequently Asked Questions
Who can join the NCT07820280 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07820280 currently recruiting?
Yes, NCT07820280 is actively recruiting participants. Contact the research team at drmariumkhalid.pt@gmail.com for enrollment information.
Where is the NCT07820280 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07820280 clinical trial?
NCT07820280 is sponsored by Ibadat International University, Islamabad. The principal investigator is Marium Khalid, Ms-OMPT at Ibadat International University, Islamabad. The trial plans to enroll 44 participants.